Datta Prasun K, Reddy Sreenivas, Sharma Mukut, Lianos Elias A
Laboratory of AIDS Pathogenesis and Molecular Therapeutics, Department of Neuroscience, Center for Neurovirology, Temple University School of Medicine, Philadelphia, PA 19122, USA.
Nephron Exp Nephrol. 2006;103(4):e131-8. doi: 10.1159/000092544. Epub 2006 Apr 5.
In proteinuria of glomerular origin there is upregulation of heme-oxygenase (HO), the rate-limiting enzyme of heme degradation, in the nephron in a segment-specific manner. To better characterize this phenomenon, we employed a model of proteinuria resulting from disruption of the glomerular capillary permeability barrier to protein by administration of the glomerular epithelial cell toxin puromycin aminonucleoside (PAN) to rats. In this model, we assessed nephron distribution of the expression of the inducible HO isoform, HO-1, and the role of free radicals in modulating HO-1 expression.
Rats were injected with either vehicle (dimethyl sulfoxide) or PAN or the spin trap free radical stabilizer alpha-phenyl-N-tert butyl nitrone (PBN), or with both PAN and PBN. Ten days following the PAN injection, urine protein, creatinine, nitric oxide (NO) and malonyldialdehyde (MDA) were measured. Kidney sections and protein lysates were assessed for changes in HO-1 expression by immunohistochemistry and Western blot analysis.
In control animals (DMSO or PBN alone) there was no proteinuria and very weak or absent HO-1 staining in nephron segments. PAN treatment induced proteinuria and increased urine MDA excretion. In these animals, there was a robust HO-1 expression mainly in tubules and in glomerular parietal but not visceral epithelial cells. Unilateral ureteral obstruction to interrupt glomerular filtration in animals treated with PAN abrogated tubular HO-1 expression in the kidney ipsilateral to the obstruction. Administration of PBN to PAN-treated animals reduced proteinuria and MDA excretion while it markedly augmented tubular HO-1 expression. This augmentation was prominent in tubular cells of the inner cortex/outer medulla.
These observations indicate that upregulation of nephron HO-1 following disruption of the glomerular permeability barrier occurs at sites downstream of this barrier and is mediated by a filtered HO-1 inducer(s). Scavenging of free radicals potentiates the effect of this inducer and unmasks nephron segments most and least capable of upregulating HO-1.
在肾小球源性蛋白尿中,血红素加氧酶(HO)——血红素降解的限速酶,在肾单位中呈节段特异性上调。为了更好地描述这一现象,我们采用了一种蛋白尿模型,该模型通过给大鼠注射肾小球上皮细胞毒素嘌呤霉素氨基核苷(PAN)破坏肾小球毛细血管对蛋白质的通透性屏障而导致蛋白尿。在这个模型中,我们评估了诱导型HO同工型HO-1表达的肾单位分布,以及自由基在调节HO-1表达中的作用。
给大鼠注射溶剂(二甲基亚砜)或PAN或自旋捕获自由基稳定剂α-苯基-N-叔丁基硝酮(PBN),或同时注射PAN和PBN。PAN注射后10天,测量尿蛋白、肌酐、一氧化氮(NO)和丙二醛(MDA)。通过免疫组织化学和蛋白质印迹分析评估肾切片和蛋白质裂解物中HO-1表达的变化。
在对照动物(单独使用二甲基亚砜或PBN)中,没有蛋白尿,肾单位节段中HO-1染色非常弱或无染色。PAN治疗诱导了蛋白尿并增加了尿MDA排泄。在这些动物中,主要在肾小管和肾小球壁层而非脏层上皮细胞中有强烈的HO-1表达。对接受PAN治疗的动物进行单侧输尿管梗阻以中断肾小球滤过,消除了梗阻同侧肾脏中肾小管HO-1的表达。给接受PAN治疗的动物注射PBN可减少蛋白尿和MDA排泄,同时显著增加肾小管HO-!表达。这种增加在内皮质/外髓质的肾小管细胞中尤为明显。
这些观察结果表明,肾小球通透性屏障破坏后肾单位HO-1的上调发生在该屏障下游的部位,并且由一种滤过的HO-1诱导剂介导。清除自由基增强了这种诱导剂的作用,并揭示了最能和最不能上调HO-1的肾单位节段。